SCHEMBL4717253

SCHEMBL4717253

COc1ccccc1CN1Cc2ccccc2N=C1N1CCN(C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.44
DRD2 P14416 3/20 0.44
DRD3 P35462 2/20 0.44
DRD1 P21728 1/20 0.41
GPX4 P36969 1/20 0.41
HRH3 Q9Y5N1 2/20 0.41
DRD4 P21917 1/20 0.41
HRH2 P25021 1/20 0.41
SIGMAR1 Q99720 1/20 0.40
KCNH2 Q12809 1/20 0.39
GRIN2B Q13224 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
GNAI3 P08754 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
ADORA2A P29274 1/20 0.39
JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL3220918 0.91 HTR1A (0.42) HTR6
Fumaric Acid SCHEMBL3220938 0.91 HTR1A (0.42) HTR6
SCHEMBL3220411 0.89 GNAI3 (0.47) HTR6DRD2DRD3SIGMAR1KCNH2
SCHEMBL4714296 0.88 KDM4E (0.47) DRD4SIGMAR1KCNH2
Fumaric Acid SCHEMBL3221298 0.81 KDM4E (0.48) SIGMAR1
Fumaric Acid SCHEMBL3221286 0.81 KDM4E (0.48) SIGMAR1
SCHEMBL15914294 0.80 MEN1 (0.39) GRIN2B
SCHEMBL3207054 0.80 MEN1 (0.36) DRD2DRD4GRIN2B
SCHEMBL3215576 0.79 SIGMAR1 (0.44) HTR6SIGMAR1GRIN2BGNAI3
SCHEMBL3207059 0.79 KMT2A (0.38) DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917245-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS Abbott GmbH & Co. KG (DE) 2008-05-07 EP disclosed
WO-2007022946-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS ABBOTT GMBH & CO. KG (DE) 2007-03-01 WO disclosed